A prospective analysis of red blood cell membrane polyunsaturated fatty acid levels and risk of non-Hodgkin lymphoma

Leuk Lymphoma. 2022 Dec;63(14):3351-3361. doi: 10.1080/10428194.2022.2131419. Epub 2022 Oct 18.

Abstract

Published studies report inconsistent associations of polyunsaturated fatty acid (PUFA) intake with non-Hodgkin lymphoma (NHL) risk. We conducted a nested case-control study in Nurses' Health Study and Health Professionals Follow-Up Study participants to evaluate a hypothesis of inverse association of pre-diagnosis red blood cell (RBC) membrane PUFA levels with risk of NHL endpoints. We confirmed 583 NHL cases and matched 583 controls by cohort/sex, age, race and blood draw date/time. We estimated odds ratios (OR) and 95% confidence intervals (CI) for risk of NHL endpoints using logistic regression. RBC PUFA levels were not associated with all NHL risk; cis 20:2n-6 was associated with follicular lymphoma risk (OR [95% CI] per one standard deviation increase: 1.35 [1.03-1.77]), and the omega-6/omega-3 PUFA ratio was associated with diffuse large B-cell lymphoma risk (2.33 [1.23-4.43]). Overall, PUFA did not demonstrate a role in NHL etiology; the two unexpected positive associations lack clear biologic explanations.

Keywords: Red blood cell membrane fatty acids; epidemiology; etiology; non-Hodgkin lymphoma; polyunsaturated fatty acids; prospective.

MeSH terms

  • Case-Control Studies
  • Cell Membrane
  • Fatty Acids, Omega-3*
  • Follow-Up Studies
  • Humans
  • Lymphoma, Non-Hodgkin* / etiology
  • Risk Factors

Substances

  • Fatty Acids, Omega-3